Avalglucosidase alfa

Nexviazyme

100 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 9 Feb 2022

In other countries

The same active substances on other registers, the same brand first.

Nexviazyme Powder for Concentrate for Solution for Infusion 100MG/VialSingapore · 100mg/vial · injection, powder, lyophilized, for solution · Sanofi-Aventis Singapore Pte. LTD.Same brand
Nexviadyme 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 10 mg/ml · polvo para concentrado para solución para perfusión · Sanofi B.V.Same substance
NexviadymeEuropean Union · Sanofi B.V.Same substance
NexviadymeCroatiaSame substance
NexviadymeItaly · Polvere per concentrato per soluzione per infusione · Sanofi B.V.Same substance
Nexviadyme100 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Sanofi B.V.Same substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Avalglucosidase alfa

Nexviazyme

100 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 9 Feb 2022

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Avalglucosidase alfa
Strength: 100 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 9 Feb 2022
Registration: DIN 02522365
Marketing authorisation holder: Sanofi-Aventis Canada INC
ATC code: A16AB22
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION, SCHEDULE D